Prokineticin 2β peptide and its use
US7612163B1 · kind B1 · utility
0Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 29, 2005 |
| Grant date | Nov 3, 2009 |
| Priority date | — |
| Expiry date | Mar 29, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A PK2β peptide is described, which, as an agonist of prokineticin receptor 1, is useful for treating lung and gastrointestinal diseases or disorders mediated by PKR1 activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.